[go: up one dir, main page]

ATE165598T1 - Heteroatom-substituierte liganden und metallkomplexe davon - Google Patents

Heteroatom-substituierte liganden und metallkomplexe davon

Info

Publication number
ATE165598T1
ATE165598T1 AT94108968T AT94108968T ATE165598T1 AT E165598 T1 ATE165598 T1 AT E165598T1 AT 94108968 T AT94108968 T AT 94108968T AT 94108968 T AT94108968 T AT 94108968T AT E165598 T1 ATE165598 T1 AT E165598T1
Authority
AT
Austria
Prior art keywords
metal complexes
heteroatom substituted
substituted ligands
heteroatom
complexes
Prior art date
Application number
AT94108968T
Other languages
English (en)
Inventor
Kondareddiar Ramalingam
Natarajan Raju
Original Assignee
Bracco Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22141146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE165598(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bracco Int Bv filed Critical Bracco Int Bv
Application granted granted Critical
Publication of ATE165598T1 publication Critical patent/ATE165598T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/62—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT94108968T 1993-06-15 1994-06-10 Heteroatom-substituierte liganden und metallkomplexe davon ATE165598T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7798193A 1993-06-15 1993-06-15

Publications (1)

Publication Number Publication Date
ATE165598T1 true ATE165598T1 (de) 1998-05-15

Family

ID=22141146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94108968T ATE165598T1 (de) 1993-06-15 1994-06-10 Heteroatom-substituierte liganden und metallkomplexe davon

Country Status (19)

Country Link
US (5) US5608110A (de)
EP (1) EP0629617B2 (de)
JP (1) JP3835831B2 (de)
KR (1) KR100346795B1 (de)
CN (1) CN1055685C (de)
AT (1) ATE165598T1 (de)
AU (1) AU678001B2 (de)
CA (1) CA2125895C (de)
CZ (1) CZ295519B6 (de)
DE (1) DE69409870T3 (de)
DK (1) DK0629617T3 (de)
ES (1) ES2115805T3 (de)
FI (1) FI942795L (de)
HU (1) HU9401777D0 (de)
IL (1) IL109925A (de)
NO (1) NO305078B1 (de)
PL (1) PL303843A1 (de)
RU (1) RU94022254A (de)
ZA (1) ZA944201B (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359120B1 (en) * 1991-10-29 2002-03-19 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia-localizing moiety
WO1994008949A2 (en) * 1992-10-08 1994-04-28 Amersham International Plc Metal-oxime chelates for use as radiopharmaceutical agents
CA2163232A1 (en) * 1993-05-20 1994-12-08 Robert C. Brasch Macromolecular contrast media for mr imaging
WO1995004552A2 (en) * 1993-08-04 1995-02-16 Amersham International Plc Radiometal complexes that localise in hypoxic tissue
IL111592A0 (en) * 1993-12-14 1995-01-24 Bracco Int Bv Stable multilayer lyophile
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
WO1998033935A1 (en) * 1997-01-31 1998-08-06 The University Of Alberta Method for detecting exogenous gene expression
US6004529A (en) 1997-04-11 1999-12-21 Nycomed Imaging As Chelating agents
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
EE04370B1 (et) * 1997-11-07 2004-10-15 Pharmacia & Upjohn Company Oksasolidinoonide valmistamismeetod, meetodis kasutatavad vaheühendid ja nende valmistamine
JP4199420B2 (ja) * 1998-05-15 2008-12-17 ジーイー・ヘルスケア・リミテッド 標識化グルタミンおよびリジンアナログ
JP3519302B2 (ja) 1999-02-09 2004-04-12 株式会社東海理化電機製作所 ウエビング巻取装置用プリテンショナー
US6465785B1 (en) * 2000-05-05 2002-10-15 Infrared Solutions, Inc. Apparatus and method for compensating for pixel non-uniformity in a bolometer
EP2286843A3 (de) 2000-06-02 2011-08-03 Bracco Suisse SA Arzneimitteln zur Zielgerichtung von Endothelzellen
WO2002032294A2 (en) * 2000-10-19 2002-04-25 Bracco Research Usa Radiopharmaceutical formulations
EP1337539A2 (de) * 2000-11-29 2003-08-27 Bracco International B.V. Vernetzbare sialyl lewis x analoge
US6384232B1 (en) 2001-03-27 2002-05-07 Bracco International B.V. Methods of synthesizing heteroatom-bearing ligands and intermediate used thereof
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
JP2006514915A (ja) 2002-03-01 2006-05-18 ダイアックス、コープ Ｋｄｒおよびｖｅｇｆ／ｋｄｒ結合ペプチドならびに診断および治療におけるその使用
WO2003086563A2 (en) * 2002-04-11 2003-10-23 Carbomer, Inc. Diabetes imaging probes
KR20040027404A (ko) * 2002-09-25 2004-04-01 다이소 가부시키가이샤 글리시딜프탈이미드의 제조방법
PL377763A1 (pl) * 2002-11-25 2006-02-20 Attenuon, Llc. Peptydy, które hamują angiogenezę, migrację komórek, naciekanie komórkowe i proliferację komórkową oraz kompozycje zawierające te peptydy i ich zastosowania
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
EP2284180B1 (de) 2003-03-03 2015-09-09 Dyax Corp. Verwendungen von Spezifisch an HGF-Rezeptor (cMET) bindenden Peptiden
WO2005009393A2 (en) * 2003-07-24 2005-02-03 Bracco Imaging S.P.A. Stable radiopharmaceutical compositions and methods for preparation
JP2008501624A (ja) * 2003-11-18 2008-01-24 アテニュオン， エルエルシー ウロキナーゼのアミノ末端断片と結合する抗体および／または抗体コンジュゲート、その組成物ならびに使用
WO2006039505A2 (en) 2004-09-30 2006-04-13 Molecular Devices Corporation Luminescent lanthanide complexes
KR100675356B1 (ko) * 2005-04-29 2007-02-01 경희대학교 산학협력단 액체 또는 초임계상태의 유체를 이용하여 금속이온 및금속산화물을 추출하는 금속추출에 사용되는 신규한 아미드화합물을 포함하는 킬레이트제와 상기 킬레이트제를이용한 금속추출방법 및 금속추출시스템
CA2680606C (en) 2006-03-29 2014-08-05 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP2007297305A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
PT2117571T (pt) * 2006-12-08 2017-06-14 Monopar Therapeutics Inc Resumo
EP2111237B1 (de) 2006-12-11 2015-03-18 BRACCO IMAGING S.p.A. Fibrin-bindende peptide und ihre konjugate
GB0804406D0 (en) * 2008-03-10 2008-04-16 Univ Zuerich Metal complexes
EP2147684A1 (de) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Selektiv gegen Metallproteasen wirkende Diagnosemittel
WO2010107832A1 (en) 2009-03-17 2010-09-23 Bracco Imaging Spa Lhrh-ii peptide analogs
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
FR2989085A1 (fr) * 2012-04-05 2013-10-11 Commissariat Energie Atomique Radiotraceurs, procedes de preparation et applications
WO2015171543A1 (en) 2014-05-05 2015-11-12 California Institute Of Technology Mutant akt-specific capture agents, compositions, and methods of using and making
EP3322716B1 (de) 2015-07-15 2025-02-12 California Institute of Technology Il-17f-spezifische einfänger und verfahren zur verwendung
JP7011830B2 (ja) 2015-10-14 2022-01-27 エックス－サーマ インコーポレイテッド 氷晶形成を低減するための組成物および方法
KR102771920B1 (ko) 2016-02-09 2025-02-25 브라코 스위스 에스.에이. 셀렉틴 표적화를 위한 재조합 키메라 단백질
CN115109120A (zh) 2016-04-04 2022-09-27 英蒂分子公司 Cd8-特异性捕获剂、组合物及使用和制备方法
US9643939B1 (en) 2016-04-18 2017-05-09 Optimus Drugs Private Limited Process for the preparation of linezolid
USRE47606E1 (en) 2016-04-21 2019-09-17 Optimus Drugs Private Limited Process for the preparation of linezolid
CN109563088B (zh) 2016-07-06 2022-10-11 密歇根大学董事会 MEK/PI3K和mTOR/MEK/PI3K的多功能抑制剂和治疗用途
EP3519425B1 (de) 2016-09-29 2024-02-28 Indi Molecular, Inc. Zusammensetzungen zum nachweis, zur hemmung und zur bildgebung von indolamin 2,3-dioxygenase 1 (ido1) und verfahren zur herstellung und verwendung davon
EP3535278A4 (de) 2016-11-01 2020-06-24 Ohio State Innovation Foundation Verfahren zur jodierung von biomolekülen
JP7110110B2 (ja) * 2016-11-09 2022-08-01 株式会社クラレ 酸素吸収剤
WO2018232345A1 (en) 2017-06-15 2018-12-20 Indi Molecular, Inc. Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
WO2019093699A1 (ko) * 2017-11-09 2019-05-16 서울대학교 산학협력단 셀레노사마필린 a와 그 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
KR102083180B1 (ko) 2017-11-09 2020-03-02 서울대학교산학협력단 셀레노사마필린 a와 그 유도체, 이의 제조방법, 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
WO2019203131A1 (ja) * 2018-04-19 2019-10-24 株式会社クラレ 不飽和二重結合含有化合物、それを用いた酸素吸収剤、及び樹脂組成物
IL271681A (en) 2018-07-18 2020-01-30 Vyripharm Entpr Llc Systems and methods for integrated and comprehensive management of cannabis products
US11638764B2 (en) 2018-11-08 2023-05-02 Indi Molecular, Inc. Theranostic capture agents, compositions, and methods of using and making
US20200291391A1 (en) 2019-03-12 2020-09-17 Indi Molecular, Inc. Cross-linked epitopes and methods of use thereof
WO2020236952A1 (en) 2019-05-20 2020-11-26 Ohio State Innovation Foundation Apohemoglobin-haptoglobin complexes and methods of using thereof
WO2020236969A1 (en) 2019-05-20 2020-11-26 Indi Molecular, Inc. Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
US11414460B2 (en) 2019-07-19 2022-08-16 Institute For Systems Biology KRAS-specific capture agents, compositions, and methods of making and using
WO2022098745A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, delivery systems, and methods useful in tumor therapy
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
WO2023009521A1 (en) 2021-07-26 2023-02-02 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound
CN114907562B (zh) * 2022-01-29 2023-08-18 华东理工大学 β-内酰胺单体的合成及聚合方法
WO2024258974A1 (en) * 2023-06-12 2024-12-19 Regents Of The University Of Minnesota Ligands and complexes and uses thereof
WO2025245032A1 (en) 2024-05-20 2025-11-27 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3369121A (en) * 1966-04-06 1968-02-13 Squibb & Sons Inc Radioactive package and container therefor
US3920995A (en) * 1973-05-04 1975-11-18 Squibb & Sons Inc Radioactive material generator
US4071613A (en) * 1976-02-26 1978-01-31 Abbott Laboratories Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
US4311689A (en) * 1978-03-02 1982-01-19 The Radiochemical Centre Limited Method and container for production of diagnostic scanning
US4193979A (en) * 1978-05-22 1980-03-18 G. D. Searle & Co. Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]carbonyl]-2-pyridinecarboxylic acid and related compounds labeled with technetium-99m
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4363793A (en) * 1979-08-30 1982-12-14 State University Of New York Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues
GB2093451B (en) * 1981-02-24 1984-10-31 May & Baker Ltd Nitroimidazole derivatives
US4431626A (en) * 1981-05-27 1984-02-14 The Regents Of The University Of California Tc-99m Labeled carrier for imaging
US4462992A (en) * 1982-02-08 1984-07-31 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4758682A (en) * 1983-03-17 1988-07-19 California Institute Of Technology Homogeneous coordination compounds as oxidation catalysts
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
GB8426845D0 (en) * 1984-10-24 1984-11-28 Amersham Int Plc Complexes of technetium-99m
JPS61103841A (ja) * 1984-10-26 1986-05-22 Nippon Mejifuijitsukusu Kk 放射性テクネチウム標識に供する安定な塩化第一スズ組成物
CA1243329A (en) * 1985-03-11 1988-10-18 Amersham Int Plc TECHNETIUM COMPLEXES WITH PROPYLENE-AMINE-OXIMES
US5187264A (en) * 1986-05-28 1993-02-16 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
ATE52516T1 (de) * 1986-05-28 1990-05-15 Mallinckrodt Inc Technetiumchelate fuer die bestimmung der nierenfunktion.
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5071636A (en) * 1987-12-29 1991-12-10 Nihon Medi-Physics Co., Ltd. Chelating compounds and their use
EP0381713B1 (de) * 1988-04-29 1994-01-19 Mallinckrodt, Inc. Diaminedithiol-chelatierungsmittel für radioarzneimittel
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5089249A (en) * 1988-06-10 1992-02-18 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
US5026829A (en) * 1989-01-23 1991-06-25 University Of Cincinnati Cyclo substituted propyleneamine oxime and its use as a brain imaging agent
US4895960A (en) * 1989-01-23 1990-01-23 University Of Cincinnati Cyclo substituted propyleneamine oxime and its use as a brain imaging agent
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
CN1022562C (zh) * 1989-04-08 1993-10-27 中国人民解放军第二军医大学 一种消瘤药——甲硝唑氨酸的合成方法
US5101041A (en) * 1989-04-26 1992-03-31 The Curators Of The University Of Missouri Triamines and their derivatives as bifunctional chelating agents
US5164176A (en) * 1989-06-16 1992-11-17 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
CA2034042C (en) * 1990-01-18 1999-08-17 Adrian D. Nunn Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
US5538712A (en) * 1990-06-01 1996-07-23 Institut Fur Diagnostikforschung Gmbh/An Der Freien Universitat Berlin Cyclopentadienylcarbonyl 99MTC complexes, process for their production as well as their use in diagnostics
DE4025788C2 (de) * 1990-08-10 1994-04-14 Diagnostikforschung Inst Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung sowie deren Verwendung in Diagnostik und Therapie
US5037631A (en) * 1990-10-29 1991-08-06 Mallinckrodt Medical, Inc. Technetium-99M complex for examinating the renal function
US5104638A (en) * 1990-10-29 1992-04-14 Mallinckrodt Medical, Inc. Method of making a radiopharmaceutical complex from a kit
US5116598A (en) * 1990-10-29 1992-05-26 Mallinckrodt Medical, Inc. N4 technetium-99 m complexes for use as radiopharmaceuticals
GB9028105D0 (en) * 1990-12-27 1991-02-13 Erba Carlo Spa Process for the preparation of substituted benzofuran derivatives
JP2703408B2 (ja) * 1990-12-28 1998-01-26 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
DE4107571A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Amid-chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
NZ244613A (en) * 1991-10-29 1996-05-28 Bracco International B V Subst A ligand containing a hypoxia-localising moiety, preparation thereof; a kit (optionally multivial) for preparing a metal complex containing the ligand
WO1994008949A2 (en) * 1992-10-08 1994-04-28 Amersham International Plc Metal-oxime chelates for use as radiopharmaceutical agents
EP0618191A1 (de) * 1993-04-02 1994-10-05 AMERSHAM INTERNATIONAL plc Metall-chelatierende Verbindungen

Also Published As

Publication number Publication date
EP0629617B1 (de) 1998-04-29
US5665329A (en) 1997-09-09
US5627286A (en) 1997-05-06
JPH0789922A (ja) 1995-04-04
CZ145594A3 (en) 1995-05-17
CZ295519B6 (cs) 2005-08-17
EP0629617A1 (de) 1994-12-21
KR100346795B1 (ko) 2002-11-29
DK0629617T3 (da) 1998-10-07
IL109925A0 (en) 1994-10-07
ZA944201B (en) 1995-02-08
DE69409870D1 (de) 1998-06-04
US5608110A (en) 1997-03-04
FI942795A7 (fi) 1994-12-16
NO305078B1 (no) 1999-03-29
CA2125895C (en) 2000-03-14
EP0629617B2 (de) 2007-09-26
AU678001B2 (en) 1997-05-15
PL303843A1 (en) 1994-12-27
CN1099388A (zh) 1995-03-01
FI942795A0 (fi) 1994-06-13
KR950000671A (ko) 1995-01-03
HU9401777D0 (en) 1994-09-28
NO942231D0 (no) 1994-06-14
ES2115805T3 (es) 1998-07-01
RU94022254A (ru) 1996-04-20
CN1055685C (zh) 2000-08-23
DE69409870T2 (de) 1998-12-10
NO942231L (no) 1994-12-16
AU6467294A (en) 1994-12-22
CA2125895A1 (en) 1994-12-16
FI942795L (fi) 1994-12-16
DE69409870T3 (de) 2008-03-13
US5741912A (en) 1998-04-21
US5656254A (en) 1997-08-12
IL109925A (en) 2005-12-18
JP3835831B2 (ja) 2006-10-18

Similar Documents

Publication Publication Date Title
ATE165598T1 (de) Heteroatom-substituierte liganden und metallkomplexe davon
FI946157L (fi) Polyaminoituja ligandeja ja niiden metallikomplekseja
FI891310A7 (fi) Piisilloitettuja siirtymämetalliyhdisteitä
ATE156838T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren 5-alpha-reduktases
DE68916345D1 (de) Thermit-Überzug.
DE68906740D1 (de) Metallische zusammensetzung enthaltend zinkoxyd-whisker.
DE68908273D1 (de) Metal radionukleid-chelatverbindungen mit verbesserter chelatierungskinetik.
FI960849L (fi) Metallikomplekseja sisältäviä farmaseuttisia koostumuksia
ATE84537T1 (de) Neue titankatalysatoren.
ATE158300T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-cholestan-on n als inhibitoren 5-alpha-reduktases
DE69114986D1 (de) Eine Phosphino-Binapthyl-Verbindung und Übergangsmetall-Komplexe davon.
DE69432022D1 (de) Polyazacycloalkane als doppelte chelatbildner
FI932035A0 (fi) Tricykliska foereningar innehaollande heteroatomer
BR8401326A (pt) Corpo de metal sinterizado provido de ao menos uma endentacao
FI943452A7 (fi) Organosiloksaanisidotut transitiometallikompleksit
NO934002L (no) Fremgangsmåte for fremstilling av metallkomplekser av N- hydroksyalkyl-tri-N-karboksyalkyl-1,4,7,10-tetraazasyklododekan- og N- etraazasyklotetradekanderivater
DE3887388D1 (de) Metall-Chelat-Verbindung und härtbares Anstrichmittel davon.
DE58908552D1 (de) Übergangsmetallkomplexe.
DE69200351D1 (de) Verfahren zur Direktnitridierung von Metallen mit niedrigem Schmelzpunkt.
DE3685284D1 (de) Chlorieren von eisenhaltigen metallstoffen.
NO892189L (no) Trijodbenzenforbindelser og kontrastmidler for radiografiinneholdende disse.
DK472085D0 (da) Metalcomplexer af bis-indolforbindelser
FR2706023B1 (fr) Programmeur analogique amélioré pour fours.
KR890013197A (ko) 함크롬 용철의 제조방법
ATE161899T1 (de) Komplexverbindungen mit oligomerem bis polymerem charakter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee